Iron Deficiency Guidance Varies in Premenopausal Women
-
By
-
Andrea Surnit
-
June 11, 2026
-
5 min
By
Andrea Surnit
June 11, 2026
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026
A JAMA Internal Medicine Viewpoint urges clinicians and health systems to verify risk-model inputs before acting on automated breast cancer screening recommendations.
by Kerri Miller
June 23, 2026
A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.
July 6, 2026